CompletedNot Applicable

Impact of a Regional Antimicrobial Stewardship on the Length of Stay of Patients Admitted to Hospital With Pneumonia

Canada1,400 participantsStarted 2015-04

Plain-language summary

This study evaluates the effectiveness of an antimicrobial stewardship program to reduce the length of stay of patients admitted to hospital with a diagnosis of pneumonia. The antimicrobial stewardship program will be implemented in several hospitals in Ontario, Canada. The program will identify patients with pneumonia, review their charts and make recommendations to their attending physicians about antibiotic management.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Community-acquired pneumonia * Immunocompetent * Age \> 18 years Exclusion Criteria: * Admitted to an intensive care unit or high intensity unit * Requiring invasive or non-invasive ventilation * Life expectancy less than 3 months * Hospitalization within the previous 3 months for at least 48 consecutive hours * Immunocompromised defined as defined as having leukemia, lymphoma, HIV with CD4 count \<=200, splenectomy or on cytotoxic chemotherapy * Neutropenic \[defined as a PMN count\<=0.5x109 cells/L\] from any cause * Receiving immunosuppressants \[defined as \>=40 mg prednisone daily (or steroid equivalent) for \>=2 weeks preceding hospitalization OR any other immunosuppressant used for systemic illness OR to prevent transplant rejection

What they're measuring

Length of hospital stay

Timeframe: Days from time of admission to time of discharge from hospital to a maximum of 14 days from the date of admission (or time to censoring at 14 days from the date of admissionor competing event depending on which comes first)

Trial details

NCT IDNCT02276092

SponsorRoyal Victoria Hospital, Canada

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-03